Portfolio company
Etherna
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops mRNA and lipid nanoparticle technologies for pharmaceutical and biotechnology partners to create nucleic acid-based medicines and vaccines.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Starna Therapeutics
This biotechnology company develops messenger RNA medicines and extrahepatic delivery systems for pharmaceutical firms and clinical researchers.
Kerna
This company develops an artificial intelligence platform to design and deliver messenger ribonucleic acid medicines for patients with previously untreatable conditions.
Novarna
This company develops an artificial intelligence platform to design and validate RNA therapeutics for biopharmaceutical partners.
Sensible Biotechnologies
This company develops a cell-based platform to produce mRNA for pharmaceutical firms and biotechnology researchers developing therapeutics and vaccines.
Nuntius Therapeutics
This company develops mRNA and gene-editing therapies using a programmable nanocarrier delivery platform for pharmaceutical companies and research institutions.
Xterna
The company develops enhanced nucleic acids to provide targeted drug delivery solutions for pharmaceutical and biotechnology researchers seeking to treat previously inaccessible diseased tissues.
Adalid Science
Adalid Sciences develops lipid nanoparticle delivery systems for nucleic acid therapeutics, serving pharmaceutical companies, biotechnology start-ups, and contract development and manufacturing organisations.
Averna Therapeutics
This biotechnology company develops genomic medicines using RNA-based technology to insert therapeutic genes into safe genomic locations for patients with various diseases.
